Yoshiaki Goto

Dr. Yoshiaki Goto


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
YGYoshiaki Goto
Yoshiaki Goto
SYSo Yamada
So Yamada
SYShoko M Yamada
Shoko M Yamada
HNHiroshi Nakaguchi
Hiroshi Nakaguchi
KHKatsumi Hoya
Katsumi Hoya
AMAkira Matsuno
Akira Matsuno
Combined chemotherapy and prophylactic cranial irradiation has improved the prognosis of children with acute leukemia. However cranial irradiation carries a latent risk of the induction of secondary intracranial tumors. We encountered a patient who developed multiple intracranial radiation-induced meningiomas (RIMs) 25 years after prophylactic cranial irradiation for the treatment of acute leukemia in childhood. The patient had 3 intracranial lesions, 1 of which showed rapid growth within 6 months; another of the tumors also enlarged within a short period. All of the tumors were surgically treated, and immunohistochemistry indicated a high MIB-1 labeling index in each of the multiple lesions. In the literature, the MIB-1 labeling indices of 27 tumors from 21 patients were examined. Among them, 12 recurrent tumors showed higher MIB-1 labeling indices compared to the MIB-1 labeling indices of the non-recurrent tumors. Overall, 11 of the patients with RIM had multiple lesions and 8 cases developed recurrence (72.7%). RIM cases with multiple lesions had higher MIB-1 labeling indices compared to the MIB-1 labeling indices of cases with single lesions. Collectively, these data showed that the MIB-1 labeling index is as important for predicting RIM recurrences, as it is for predicting sporadic meningioma (SM) recurrences. RIMs should be treated more aggressively than SMs because of their greater malignant potential.

26 April 2013 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
SYShoko Merrit Yamada
Shoko Merrit Yamada
YIYudo Ishii
Yudo Ishii
SYSo Yamada
So Yamada
YGYoshiaki Goto
Yoshiaki Goto
MMMineko Murakami
Mineko Murakami
AMAkira Matsuno
Akira Matsuno
CyberKnife® radiation is an effective treatment for unresectable skull base tumors because it can deliver a highly conformational dose distribution to the complex shapes of tumor extensions. There have been few reports of severe complications with this treatment. This is the first published case report to our knowledge of cerebrospinal fluid leakage induced by CyberKnife® radiotherapy.